Immune-related adverse events by MMR cohort
| dMMR | pMMR | |||
| Any grade | Grade 3 or higher | Any grade | Grade 3 or higher | |
| Eligible patients who received at least one dose of study treatment | 35 | 34 | ||
| Patients who experienced at least one immune-related event, n (%) | 7 (20) | 7 (21) | 1 (3) | |
| Immune-related events, n (%) | ||||
| Hyperthyroidism | 5 (14) | 2 (6) | ||
| Hypothyroidism | 3 (9) | 3 (9) | ||
| Pneumonitis | 1 (3) | 1 (3) | ||
| Adrenal insufficiency | 1 (3) | 0 | ||
| Viral hepatitis | 0 | 1 (3) | 1 (3) | |
dMMR, mismatch repair deficient; MMR, mismatch mutation repair; pMMR, mismatch repair proficient.